USANA Health Sciences Reports First Quarter 2019 Results

Go back to USANA Health Sciences Reports First Quarter 2019 Results

USANA Health Sciences Inc. (USNA) PT Raised to $105 at Pivotal Research

May 1, 2019 1:22 PM EDT

Pivotal Research analyst Timothy Ramey raised the price target on USANA Health Sciences Inc. (NYSE: USNA) to $105.00 (from $95.00) while maintaining a Buy rating.

Ramey commented, "USNAs 1Q19 EPS at $1.01 vs. was in line with the pre-release range and our $1.00 estimate. As previously... More

USANA Health Sciences (USNA) Tops Q1 EPS by 2c, Slight Beat on Revenues; Affirms FY19 EPS/Revenue Guidance

April 30, 2019 4:20 PM EDT

USANA Health Sciences (NYSE: USNA) reported Q1 EPS of $1.01, $0.02 better than the analyst estimate of $0.99. Revenue for the quarter came in at $273 million versus the consensus estimate of $272.09 million.

Results in-line with preliminary results provided on April 2, 2019First quarter net sales of $273.0 millionFirst quarter net earnings of $24.2 million, or $1.01 per shareCompany... More